The SPARC tokamak is a critical next step towards commercial fusion energy. SPARC is designed as a high-field (
$B_0 = 12.2$
T), compact (
$R_0 = 1.85$
m,
$a = 0.57$
m), superconducting, D-T tokamak with the goal of producing fusion gain
$Q>2$
from a magnetically confined fusion plasma for the first time. Currently under design, SPARC will continue the high-field path of the Alcator series of tokamaks, utilizing new magnets based on rare earth barium copper oxide high-temperature superconductors to achieve high performance in a compact device. The goal of
$Q>2$
is achievable with conservative physics assumptions (
$H_{98,y2} = 0.7$
) and, with the nominal assumption of
$H_{98,y2} = 1$
, SPARC is projected to attain
$Q \approx 11$
and
$P_{\textrm {fusion}} \approx 140$
MW. SPARC will therefore constitute a unique platform for burning plasma physics research with high density (
$\langle n_{e} \rangle \approx 3 \times 10^{20}\ \textrm {m}^{-3}$
), high temperature (
$\langle T_e \rangle \approx 7$
keV) and high power density (
$P_{\textrm {fusion}}/V_{\textrm {plasma}} \approx 7\ \textrm {MW}\,\textrm {m}^{-3}$
) relevant to fusion power plants. SPARC's place in the path to commercial fusion energy, its parameters and the current status of SPARC design work are presented. This work also describes the basis for global performance projections and summarizes some of the physics analysis that is presented in greater detail in the companion articles of this collection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.